CONMED Corporation (NYSE:CNMD) Q2 2023 Earnings Conference Call July 26, 2023 4:30 PM ET

Company Participants

Curt Hartman - Chairman, President, and CEO

Todd Garner - EVP and CFO

Conference Call Participants

Robert Marcus - JPMorgan

Rick Wise - Stifel

Matthew O'Brien - Piper Sandler

Vik Chopra - Wells Fargo

Matthew Mishan - KeyBanc

Young Li - Jefferies

Kristen Stewart - C.L. King

Mike Matson - Needham & Company

Operator

Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risks and uncertainties as those terms are defined under the federal securities laws.

Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results. The company's actual results may differ materially from its current expectations.

Please refer to the risks and other uncertainties disclosed under the forward-looking information in today's press release as well as the company's SEC filings for more detail on the risks and uncertainties that may cause actual results to differ materially.

The company disclaims any obligation to update any forward-looking statements that may be discussed during this call, except as may be required by applicable law. You will also hear management refer to non-GAAP or adjusted measurements during this discussion.

While these figures are not a suitable substitute for GAAP measurements, management uses these figures to aid in monitoring the company's ongoing financial performance from quarter-to-quarter and year-to-year on a regular basis and for benchmarking against other medical technology companies.

Adjusted net income and adjusted earnings per share measure the income of the company, excluding credit or charges that are considered by the company to be special or outside of its normal ongoing operation. These adjusting items are specified in the reconciliation supporting the company's earnings releases posted to the company's website.

With these required announcements completed, I will now turn the call over to Curt Hartman, CONMEDs, Chair of the Board, President and Chief Executive Officer, for opening remarks. Mr. Hartman?

Curt Hartman

Thank you, Jonathan. Good afternoon and thank you for joining us for CONMED's Second Quarter 2023 Earnings Call. With me on the call is Todd Garner, Executive Vice President and Chief Financial Officer. Our plan is to share with you our second quarter results and then open the call to your questions.